U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H34O2.C12H26N4O6
Molecular Weight 604.8194
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of NEAMINE OLEATE

SMILES

CCCCCCCC\C=C/CCCCCCCC(O)=O.NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O

InChI

InChIKey=DZJNRUAMSDNLDC-AWCLPILZSA-N
InChI=1S/C18H34O2.C12H26N4O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;13-2-5-8(18)9(19)6(16)12(21-5)22-11-4(15)1-3(14)7(17)10(11)20/h9-10H,2-8,11-17H2,1H3,(H,19,20);3-12,17-20H,1-2,13-16H2/b10-9-;/t;3-,4+,5-,6-,7+,8-,9-,10-,11-,12-/m.1/s1

HIDE SMILES / InChI

Molecular Formula C18H34O2
Molecular Weight 282.4614
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Molecular Formula C12H26N4O6
Molecular Weight 322.358
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Neamine inhibits cell proliferation, migration, and invasion in H7402 human hepatoma cells.
2010-12
Aminoglycoside binding to Oxytricha nova telomeric DNA.
2010-11-16
Mutation K42R in ribosomal protein S12 does not affect susceptibility of Mycobacterium smegmatis 16S rRNA A-site mutants to 2-deoxystreptamines.
2010-08-05
Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity.
2010-05-13
Two-dimensional combinatorial screening of a bacterial rRNA A-site-like motif library: defining privileged asymmetric internal loops that bind aminoglycosides.
2010-03-09
The nebramycin aminoglycoside profiles of Streptomyces tenebrarius and their characterization using an integrated liquid chromatography-electrospray ionization-tandem mass spectrometric analysis.
2010-02-19
Synthesis and antimicrobial evaluation of amphiphilic neamine derivatives.
2010-01-14
Synthesis and transfection properties of a series of lipidic neamine derivatives.
2009-11
Synthesis of neamine-derived pseudodisaccharides by stereo- and regio-selective functional group transformations.
2009-10-21
Enantioseparation by MEKC using a ligand exchange-based chiral pseudostationary phase.
2009-08
Aminoglycosides: molecular insights on the recognition of RNA and aminoglycoside mimics.
2009-04-28
Synthesis and evaluation of novel neamine derivatives effectively targeting to RNA.
2009-04-15
Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.
2009-03-15
Search for novel aminoglycosides by combining fragment-based virtual screening and 3D-QSAR scoring.
2009-02
Chiral ligand-exchange chromatography of amino acids using porous graphitic carbon coated with a dinaphthyl derivative of neamine.
2009-01
Synthesis of a phosphonate-linked aminoglycoside-coenzyme a bisubstrate and use in mechanistic studies of an enzyme involved in aminoglycoside resistance.
2009
Two-dimensional combinatorial screening identifies specific 6'-acylated kanamycin A- and 6'-acylated neamine-RNA hairpin interactions.
2008-12-02
Studies on the synthesis of neamine-dinucleosides and neamine-PNA conjugates and their interaction with RNA.
2008-10-15
Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners.
2008-08-20
Identification of tobramycin impurities for quality control process monitoring using high-performance anion-exchange chromatography with integrated pulsed amperometric detection.
2008-08-05
Copper(II) complexes of lipophilic aminoglycoside derivatives for the amino acid enantiomeric separation by ligand-exchange liquid chromatography.
2008-03-28
Biosynthesis of 3'-deoxy-carbamoylkanamycin C in a Streptomyces tenebrarius mutant strain by tacB gene disruption.
2008-02
Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
2008-01
Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
2007-12
Synthesis of a neamine dimer targeting the dimerization initiation site of HIV-1 RNA.
2007-10-25
Design and synthesis of a structurally constrained aminoglycoside.
2007-07-06
Unique O-ribosylation in the biosynthesis of butirosin.
2007-07-01
Aminoglycoside antibiotic derivatives: preparation and evaluation of toxicity on cochlea and vestibular tissues and antimicrobial activity.
2007-06-01
Monitoring aminoglycoside-induced conformational changes in 16S rRNA through acrylamide quenching.
2007-06-01
Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery.
2007-03-21
Elaboration of neosamine rings in the biosynthesis of neomycin and butirosin.
2007-02-12
Determination of neomycin sulfate and impurities using high-performance anion-exchange chromatography with integrated pulsed amperometric detection.
2007-01-04
Nucleobase modified neamines, their synthesis and binding specificity for HIV TAR RNA.
2007
Mechanism of RNA cleavage catalyzed by sequence specific polyamide nucleic acid-neamine conjugate.
2007
Synthesis and antibacterial activity of novel neamine derivatives.
2006-12-15
Selectively guanidinylated derivatives of neamine. Syntheses and inhibition of anthrax lethal factor protease.
2006-10-01
A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns.
2006-08
Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.
2006-07
Cationic polyamines inhibit anthrax lethal factor protease.
2006-06-08
Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat.
2006-04-15
Determination of tobramycin and impurities using high-performance anion exchange chromatography with integrated pulsed amperometric detection.
2006-03-03
Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site.
2006-02
Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice.
2005-12-15
Neamine dimers targeting the HIV-1 TAR RNA.
2005-11-01
The RNA-bound conformation of neamine as determined by transferred NOE experiments.
2005-07
Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
2005-04-15
Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy.
2004-11-19
Chemoenzymatic synthesis and high-throughput screening of an aminoglycoside-polyamine library: identification of high-affinity displacers and DNA-binding ligands.
2004-10-06
Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.
1993-09-24
Screening for new compounds with antiherpes activity.
1984-10
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:37:06 GMT 2025
Edited
by admin
on Mon Mar 31 17:37:06 GMT 2025
Record UNII
0S0TGD9Q4H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEKAMYCIN V OLEATE
Preferred Name English
NEAMINE OLEATE
Common Name English
NEOMYCIN A OLEATE
Common Name English
Code System Code Type Description
PUBCHEM
123133436
Created by admin on Mon Mar 31 17:37:06 GMT 2025 , Edited by admin on Mon Mar 31 17:37:06 GMT 2025
PRIMARY
FDA UNII
0S0TGD9Q4H
Created by admin on Mon Mar 31 17:37:06 GMT 2025 , Edited by admin on Mon Mar 31 17:37:06 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE